MedPath

Prognostic Significance of the Uncertain Resection in NSCLC

Active, not recruiting
Conditions
Non Small Cell Lung Cancer
Residual; State
Interventions
Procedure: Complete lymphadenectomy
Procedure: Incomplete lymphadenectomy
Registration Number
NCT06511661
Lead Sponsor
Sun Yat-sen University
Brief Summary

The concept of residual tumor classification proposed by the Union for International Cancer Control (UICC) was used to assess the completeness of surgical resection, and non-small cell lung cancer (NSCLC) patients with incomplete resection were more likely to occur recurrence, leading to significantly poor survival. But this R classification only refers to the surgical margin and neglects other factors associated with surgical quality, such as the extent of lymph node dissection (LND). Therefore, the International Association for the Study of Lung Cancer (IASLC) proposed the definition of uncertain resection \[R(un)\], which includes the suboptimal extent of LND. However, the clinical significance of R(un) is still controversial. On the one hand, some researches demonstrated that R(un) had definite prognostic significance, with R(un) survival stratifying between R0 and R1. On the other hand, some studies indicated that in early-stage NSCLC, the suboptimal extent of LND had no impact on survival, and the concept of R(un) might be insignificant in these patients. Even in those studies supporting the prognostic significance of R(un), which kind of patients is suitable for R(un) was still unclear. Thus, the investigators explore the impact of the R(un) on the long-term survival of patients with NSCLC using a large cohort in China, to identify those patients who could really benefit from the LND required by the R0 classification proposed by IASLC.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
3783
Inclusion Criteria
  1. Primary non-small cell lung cancer
  2. With pulmonary resection
Exclusion Criteria
  1. Sublobar resection
  2. R1/R2
  3. Positive highest mediastinal lymph nodes
  4. Operative death

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
R0 groupComplete lymphadenectomyPatients with NSCLC who underwent R0 surgery according to the R stage proposed by IASLC.
R(un) groupIncomplete lymphadenectomyPatients with NSCLC who underwent R(un) surgery according to the R stage proposed by IASLC.
Primary Outcome Measures
NameTimeMethod
5-year disease-free survival5 years after surgery

The disease-free survival rate 5 years after surgery

5-year overall survival5 years after surgery

The overall survival rate 5 years after surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sun Yat-sen University Cancer Center

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath